With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Fortanix® Inc., a leader in data-first cybersecurity and pioneer of Confidential Computing, today announced that Xeureka Inc., a subsidiary of Mitsui & Co.
The biopharmaceutical industry is facing unprecedented challenges to its fundamental business model and currently cannot sustain sufficient innovation to replace its products and revenues lost due to ...
AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment and de-risking projects. Digital tools bridge R&D and manufacturing, ...
Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, validation, and life cycle controls that hybrid architectures can operationalize.
A government initiative is developing advanced alternative testing methods that use no animals in the pharmaceutical development process. In a joint project with the Ministry of Science and ICT and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results